HIBM is caused by problems on an enzyme known as GNE. Developing therapies for enzyme related muscle diseases have been historically less difficult that muscle wasting diseases caused by large structural proteins. Thus, we are hopeful that therapy can be developed in the near future.
To learn more about how therapies are developed, you may visit HRG website, developing therapy, and research articles.